Atlas Trials

Prospective Study of VEGFR-2 /IL-8 Genetic Interaction in MBC Treated With Paclitaxel and Bevacizumab vs. Chemotherapy

Clinical trial NCT02329639 · COMPLETED

Trial details

NCT number
NCT02329639
Sponsor
University of Pisa
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Breast Cancer
Start date
2014-04-01
Primary completion
2025-10-01
Enrollment
307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.